Overview

Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)

Status:
Terminated

Trial end date:
2015-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the long term safety and tolerability of fostamatinib in patients with rheumatoid arthritis (RA).

Phase:

Phase 3

Details

Lead Sponsor:

AstraZeneca